Aviv Reisfeld

Director/Board Member at Medifreeze Ltd.

51 year

Consumer Services

Finance

Commercial Services

Profile

Aviv Reisfeld is currently a Director at Medifreeze Ltd.
and also holds the position of General Counsel at Hadasit Medical Research Services & Development Ltd.
He previously worked as a Director at HBL- Hadasit Bio-Holdings Ltd.
from 2018 to 2021.
Mr. Reisfeld has a graduate degree from the University of Warwick and an MBA from Bar-Ilan University.

Aviv Reisfeld active positions

Companies	Position	Start
Medifreeze Ltd.	Director/Board Member	-
Hadasit Medical Research Services & Development Ltd. Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel.	General Counsel	31/10/2007

All active positions of Aviv Reisfeld

Former positions of Aviv Reisfeld

Companies	Position	End
HBL - HADASIT BIO-HOLDINGS LTD	Director/Board Member	28/03/2021

See the detail of Aviv Reisfeld's experience

Training of Aviv Reisfeld

Bar-Ilan University	Masters Business Admin
University of Warwick	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Aviv Reisfeld's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HBL - HADASIT BIO-HOLDINGS LTD	Finance

Private companies	2
Medifreeze Ltd.
Hadasit Medical Research Services & Development Ltd. Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel.	Commercial Services